John H. Cleator

825 total citations
19 papers, 503 citations indexed

About

John H. Cleator is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, John H. Cleator has authored 19 papers receiving a total of 503 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 9 papers in Molecular Biology and 4 papers in Surgery. Recurrent topics in John H. Cleator's work include Antiplatelet Therapy and Cardiovascular Diseases (6 papers), Protein Kinase Regulation and GTPase Signaling (5 papers) and Receptor Mechanisms and Signaling (4 papers). John H. Cleator is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (6 papers), Protein Kinase Regulation and GTPase Signaling (5 papers) and Receptor Mechanisms and Signaling (4 papers). John H. Cleator collaborates with scholars based in United States and Italy. John H. Cleator's co-authors include Heidi E. Hamm, Douglas E. Vaughan, Joseph N. McLaughlin, John D. Hildebrandt, Michael Holinstat, Bryan Voss, Matthew L. Bilodeau, Jane Dingus, David T. Kurtz and Lia H. Campbell and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Blood.

In The Last Decade

John H. Cleator

19 papers receiving 499 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John H. Cleator United States 9 207 159 147 60 44 19 503
Marie-Claude Laplace France 12 155 0.7× 182 1.1× 167 1.1× 69 1.1× 64 1.5× 16 562
Aleksandra Stojanovic‐Terpo United States 9 171 0.8× 130 0.8× 294 2.0× 44 0.7× 37 0.8× 10 588
Hasnae Elouardighi United States 8 278 1.3× 115 0.7× 59 0.4× 25 0.4× 34 0.8× 8 440
Qiansheng Ren United States 9 222 1.1× 43 0.3× 263 1.8× 59 1.0× 22 0.5× 11 593
Raymond Piatt United States 12 116 0.6× 110 0.7× 281 1.9× 49 0.8× 54 1.2× 18 465
John Dixon United Kingdom 8 180 0.9× 122 0.8× 54 0.4× 43 0.7× 11 0.3× 11 508
Howard C.H. Chow Hong Kong 9 250 1.2× 33 0.2× 263 1.8× 41 0.7× 107 2.4× 13 491
Angelika Gillitzer Germany 6 208 1.0× 160 1.0× 126 0.9× 48 0.8× 13 0.3× 8 420
Isaac Rosa Spain 14 288 1.4× 147 0.9× 208 1.4× 27 0.5× 9 0.2× 20 556
Julio C. Reséndiz Finland 10 69 0.3× 156 1.0× 229 1.6× 85 1.4× 25 0.6× 14 396

Countries citing papers authored by John H. Cleator

Since Specialization
Citations

This map shows the geographic impact of John H. Cleator's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John H. Cleator with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John H. Cleator more than expected).

Fields of papers citing papers by John H. Cleator

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John H. Cleator. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John H. Cleator. The network helps show where John H. Cleator may publish in the future.

Co-authorship network of co-authors of John H. Cleator

This figure shows the co-authorship network connecting the top 25 collaborators of John H. Cleator. A scholar is included among the top collaborators of John H. Cleator based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John H. Cleator. John H. Cleator is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Galindo, Cristi L., et al.. (2022). Neuregulin (NRG-1β) Is Pro-Myogenic and Anti-Cachectic in Respiratory Muscles of Post-Myocardial Infarcted Swine. Biology. 11(5). 682–682. 2 indexed citations
2.
Cleator, John H., Christopher A. Wells, Jane Dingus, David T. Kurtz, & John D. Hildebrandt. (2018). The N54-αs Mutant Has Decreased Affinity for βγ and Suggests a Mechanism for Coupling Heterotrimeric G Protein Nucleotide Exchange with Subunit Dissociation. Journal of Pharmacology and Experimental Therapeutics. 365(2). 219–225. 1 indexed citations
3.
Huang, Zhihong, Douglas B. Sawyer, John H. Cleator, et al.. (2017). Species-specific effects of neuregulin-1β (cimaglermin alfa) on glucose handling in animal models and humans with heart failure. Toxicology and Applied Pharmacology. 332. 92–99. 4 indexed citations
4.
Jiang, Min, Yonghui Wu, Christian M. Shaffer, et al.. (2017). A comparative study of different methods for automatic identification of clopidogrel-induced bleedings in electronic health records.. PubMed. 2017. 185–192. 5 indexed citations
5.
Cleator, John H., et al.. (2016). How Can we Improve Non-Surgical Septal Reduction for Hypertrophic Obstructive Cardiomyopathy?. 4(4). 1 indexed citations
6.
Friedman, Eitan, Jessica Delaney, Peter Weeke, et al.. (2015). Evaluation of the F2R IVS-14A/T PAR1 polymorphism with subsequent cardiovascular events and bleeding in patients who have undergone percutaneous coronary intervention. Journal of Thrombosis and Thrombolysis. 41(4). 656–662. 6 indexed citations
7.
Galindo, Cristi L., Sergey Ryzhov, Yanna Song, et al.. (2014). Anti‐Remodeling and Anti‐Fibrotic Effects of the Neuregulin‐1β Glial Growth Factor 2 in a Large Animal Model of Heart Failure. Journal of the American Heart Association. 3(5). e000773–e000773. 67 indexed citations
8.
Cleator, John H., Matthew T. Duvernay, Michael Holinstat, et al.. (2014). Racial Differences in Resistance to P2Y12 Receptor Antagonists in Type 2 Diabetic Subjects. Journal of Pharmacology and Experimental Therapeutics. 351(1). 33–43. 4 indexed citations
9.
Delaney, Jessica, Yanna Song, Erica Bowton, et al.. (2014). Abstract 19748: CD39-associated SNP and Secondary Cardiovascular Events. Circulation. 130(suppl_2). 1 indexed citations
10.
Holinstat, Michael, et al.. (2012). Dichotomous effects of exposure to bivalirudin in patients undergoing percutaneous coronary intervention on protease-activated receptor-mediated platelet activation. Journal of Thrombosis and Thrombolysis. 35(2). 209–222. 4 indexed citations
11.
Williams, Phillip, et al.. (2011). Abstract 15531: Neuregulin-1{beta} Improves Cardiac Remodeling After MI in Swine. Circulation. 124. 2 indexed citations
12.
Delaney, Jessica, Andrea H. Ramirez, Erica Bowton, et al.. (2011). Predicting Clopidogrel Response Using DNA Samples Linked to an Electronic Health Record. Clinical Pharmacology & Therapeutics. 91(2). 257–263. 76 indexed citations
13.
Holinstat, Michael, Bryan Voss, Matthew L. Bilodeau, et al.. (2006). PAR4, but Not PAR1, Signals Human Platelet Aggregation via Ca2+ Mobilization and Synergistic P2Y12 Receptor Activation. Journal of Biological Chemistry. 281(36). 26665–26674. 96 indexed citations
14.
McLaughlin, Joseph N., Maria Rosa Mazzoni, John H. Cleator, et al.. (2005). Thrombin Modulates the Expression of a Set of Genes Including Thrombospondin-1 in Human Microvascular Endothelial Cells. Journal of Biological Chemistry. 280(23). 22172–22180. 52 indexed citations
15.
Dingus, Jane, Christopher A. Wells, Lia H. Campbell, et al.. (2005). G Protein βγ Dimer Formation:  Gβ and Gγ Differentially Determine Efficiency of in Vitro Dimer Formation. Biochemistry. 44(35). 11882–11890. 40 indexed citations
16.
17.
Cleator, John H., et al.. (2004). A Dominant Negative Gαs Mutant That Prevents Thyroid-stimulating Hormone Receptor Activation of cAMP Production and Inositol 1,4,5-Trisphosphate Turnover. Journal of Biological Chemistry. 279(35). 36601–36607. 14 indexed citations
18.
Schey, Kevin L., et al.. (2001). Identification of a region in G protein γ subunits conserved across species but hypervariable among subunit isoforms. Protein Science. 10(12). 2548–2555. 22 indexed citations
19.
Cleator, John H., Nitin D. Mehta, David T. Kurtz, & John D. Hildebrandt. (1999). The N54 mutant of Gαs has a conditional dominant negative phenotype which suppresses hormone‐stimulated but not basal cAMP levels. FEBS Letters. 443(2). 205–208. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marie-Claude Laplace Breakdown of academic impact, for papers by Aleksandra Stojanovic‐Terpo Breakdown of academic impact, for papers by Hasnae Elouardighi Breakdown of academic impact, for papers by Qiansheng Ren Breakdown of academic impact, for papers by Raymond Piatt Breakdown of academic impact, for papers by John Dixon Breakdown of academic impact, for papers by Howard C.H. Chow Breakdown of academic impact, for papers by Angelika Gillitzer Breakdown of academic impact, for papers by Isaac Rosa Breakdown of academic impact, for papers by Julio C. Reséndiz
Rankless by CCL
2026